Epidemiological studies indicate that patients with asthma–COPD overlap constitute about 1/3 of patients with obstructive airway diseases. However, in daily practice the coexistence of asthma and COPD does not seem to be diagnosed often. What are the possible reasons for this discrepancy?
If a patient enters a screening program and the first computed tomography (CT) is negative, how often are CT scans usually repeated in those with no pulmonary nodules? Is it necessary to repeat the CT scan if the first screening was negative?
In the 2017 GOLD report there was a significant change in the guidelines on inhaled corticosteroid (ICS) use. Are there still indications for ICS in chronic obstructive pulmonary disease patients who do not need triple therapy?
Family physicians are frequently approached by patients of all ages, usually asymptomatic, who request chest x-ray because “it’s been a long time since the last one.” Would you perform the study in such cases?
Are United States guidelines for lung cancer screening universal? Can they be applied to the Polish population?
Should we start pharmacological treatment in asymptomatic patients with chronic obstructive pulmonary disease?
Does lung ultrasound complement or replace the use of chest X-ray in the diagnostics of patients with lung disease?
What is your opinion on sedation of patients on noninvasive ventilation? In BTS guidelines, sedation with morphine is an optional approach in agitated patients receiving NIV.
What management would you recommend in a patient with IPF and troublesome cough? A study published some time ago suggested thalidomide was effective in the treatment of cough in patients with IPF. Is it used for this indication outside clinical trials?
In Poland, a significant proportion of cases of tuberculosis (TB) is latent TB infection, and most of the population has been vaccinated against TB. Is there still a place for tuberculin skin testing or should it be replaced with IGRAs?
English
Polski
Español
українська